Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.

YOUR CHOICE

Clinically superior solutions that last a lifetime

LATEST NEWS

Admedus welcomes new opportunities in Emerging Markets
Admedus Limited (ASX:AHZ), is pleased to announce recent developments in the Emerging Markets with the introduction of CardioCel® to Vietnam
Read more.
Admedus secures strategic investor
Admedus Limited (ASX:AHZ) is pleased to announce that Hong Kong based strategic investor, Star Bright Holding Ltd (together with its
Read more.